Cormorant Asset Management, LP
SEC-identified person · CIK 1583977 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Bright Minds Biosciences INC. DRUG | Officer | filed 2024 - 2026 |
| Corbus Pharmaceuticals Holdings, Inc. CRBP | Officer | filed 2024 - 2025 |
| Psivida LTD PSDV | Officer | filed 2023 - 2025 |
| Moonlake Immunotherapeutics MLTX | Officer | filed 2023 - 2025 |
| Biomea Fusion, Inc. BMEA | Director | filed 2021 - 2025 |
| Reneo Pharmaceuticals, Inc. RPHM | Officer | filed 2024 - 2025 |
| Aardvark Therapeutics, Inc. AARD | Officer | filed 2025 - 2025 |
| Bioage Labs, Inc. BIOA | Officer | filed 2024 - 2024 |
| Immuneering Corp IMRX | Officer | filed 2021 - 2024 |
| Ambrx Biopharma, Inc. AMAM | Officer | filed 2023 - 2023 |
| Ambrx Biopharma Inc. AMAM | Officer | filed 2023 - 2023 |
| Greenlight Biosciences Holdings, PBC GRNA | Officer | filed 2023 - 2023 |
| Erasca, Inc. ERAS | Director | filed 2021 - 2023 |
| Vigil Neuroscience, Inc. VIGL | Officer | filed 2022 - 2022 |
| Ventyx Biosciences, Inc. VTYX | Officer | filed 2021 - 2021 |
| Pyxis Oncology, Inc. PYXS | Officer | filed 2021 - 2021 |
| Tyra Biosciences, Inc. TYRA | Officer | filed 2021 - 2021 |
| Icosavax, Inc. ICVX | Officer | filed 2021 - 2021 |
| Jade Biosciences, Inc. JBIO | Officer | filed 2021 - 2021 |
| Elevation Oncology, Inc. ELEV | Officer | filed 2021 - 2021 |
| Monte Rosa Therapeutics, Inc. GLUE | Officer | filed 2021 - 2021 |
| Verve Therapeutics, Inc. VERV | Officer | filed 2021 - 2021 |
| Rain Therapeutics Inc. RAIN | Officer | filed 2021 - 2021 |
| Design Therapeutics, Inc. DSGN | Officer | filed 2021 - 2021 |
| Prometheus Biosciences, Inc. RXDX | Officer | filed 2021 - 2021 |
| Bioatla, Inc. BCAB | Officer | filed 2020 - 2020 |
| Olema Pharmaceuticals, Inc. OLMA | Officer | filed 2020 - 2020 |
| Atea Pharmaceuticals, Inc. AVIR | Officer | filed 2020 - 2020 |
| Akouos, Inc. AKUS | Officer | filed 2020 - 2020 |
| Avidity Biosciences, Inc. RNAM | Officer | filed 2020 - 2020 |
| Turning Point Therapeutics, Inc. TPTX | Officer | filed 2019 - 2019 |
| Axonics, Inc. AXNX | Officer | filed 2018 - 2018 |
| Constellation Pharmaceuticals INC CNST | Officer | filed 2018 - 2018 |
| Kezar Life Sciences, Inc. KZR | Officer | filed 2018 - 2018 |
| Kiniksa Pharmaceuticals, Ltd. KNSA | Officer | filed 2018 - 2018 |
| Yumanity Therapeutics, INC. YMTX | Officer | filed 2016 - 2017 |
| Apellis Pharmaceuticals, Inc. APLS | Officer | filed 2017 - 2017 |
| Clearside Biomedical, Inc. CLSD | Officer | filed 2016 - 2016 |
| Cellectar Biosciences, Inc. clrB | Officer | filed 2014 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.